Drug-Related Side Effects and Adverse Reactions: all 449 studies

Page 2 of 5. Open to participants first (77), then studies with results posted, then the rest; newest registration first within each.

• The Thai Surgical Intensive Care Study (Thai-SICU Study)CompletedNCT01354197Results posted
• Regional Data Exchange to Improve Medication SafetyCompletedNCT01239121Not applicableResults posted
• Eliminating Risk of Preventable Adverse Drug Events at the Hospital-community Interface of CareCompletedNCT01164137Not applicableResults posted
• Achieving Medication Safety During Acute Kidney InjuryCompletedNCT01134900Not applicableResults posted
• Implementation of Real-time ADE Surveillance and Decision SupportCompletedNCT00780572Not applicableResults posted
• Aminotransferase Trends During Prolonged Acetaminophen DosingCompletedNCT00743093Phase 4Results posted
• 05-001: Treatment of Acute Lymphoblastic Leukemia in ChildrenCompletedNCT00400946Phase 3Results posted
• Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal CancerTerminatedNCT00305643Phase 3Results posted
• Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other CancerCompletedNCT00296036Phase 3Results posted
• Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for CancerCompletedNCT00245050Phase 3Results posted
• Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast CancerTerminatedNCT00090844Phase 2Results posted
• Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment RegimenTerminatedNCT00074165Phase 2Results posted
• The Effect of the 5th Sign Intervention on Medication Adherence in Kidney Transplant RecipientsCompletedNCT07851142Not applicable
• Implementation and Assessment of a Medication Therapy Management Program in HIV Patients at High Risk of Adverse Drug Events at Khartoum, SudanCompletedNCT07750834Not applicable
• Citalopram and the Risk of Serious Adverse EventsActive, not recruitingNCT07399795
• Sertraline and the Risk of Serious Adverse EventsActive, not recruitingNCT07387120
• Impact of Medication Education on Adherence and Side EffectsCompletedNCT07374588Not applicable
• Escitalopram and the Risk of Serious Adverse EventsActive, not recruitingNCT07274241
• Neutropenia With TNF-α InhibitorsCompletedNCT07237906
• Pharmaceutical Care for Patients Using CapecitabineCompletedNCT07063706Not applicable
• Introducing Electronic Alerts to Reduce Inappropriate Digoxin Prescribing in Older AdultsActive, not recruitingNCT07008144Not applicable
• Prescription Patterns of Antidepressants, Analgesics, and Antiepileptics Drugs in Adult With Acquired Brain InjuryCompletedNCT06983314
• The INTEGRATE Study: Integrated Pharmacogenetics, TDM and Active Pharmacovigilance as Innovative Tools for the Optimisation and Appropriateness of Drug TherapyActive, not recruitingNCT06822959
• Phototoxicity of Frequently Prescribed MedicinesCompletedNCT06710600Not applicable
• Safety Study About the mRNA Vaccines Against COVID-19 in Children (PEDIVACOV-HCSC)CompletedNCT06646744
• Evaluation of the Implementation of the Pharmacogenetics and Personalized Medicine Program "MedeA" in the Extremadura Health Service.Status unknownNCT06607445
• Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Line CDK 4/6 Inhibitors and Endocrine TherapyCompletedNCT06558084
• Radiopharmaceuticals Analysis for Detailed Insights And INternational Tracking of SafetyActive, not recruitingNCT06483685
• Effect of Epstein-Barr Virus on Macrophage M2/M1 Migration and EphA2 Expression in Adverse Drug ReactionsActive, not recruitingNCT06456086
• An Evaluation of Healthcare Providers' Adherence to Pharmacovigilance Practices in an African CommunityCompletedNCT06428162
• Protective Effect of Nicotinamide Riboside Against Acetaminophen ToxicityCompletedNCT06214468Phase 1
• Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast CancerStatus unknownNCT06152471Phase 3
• Efficacy and Safety of Sertraline in the Treatment of Maintenance Hemodialysis Patients With DepressionCompletedNCT06124417Phase 4
• Effect of Intranasal Midazolam Versus Ketamine Midazolam Combination as a Premedication on the Occurrence of Postoperative Respiratory Adverse EventsCompletedNCT06122948Phase 3
• A Study of GC101 TIL in Advanced Melanoma (BZ)CompletedNCT06120712Phase 1/2
• Population Health Approach to Optimizing Medications in Older AdultsActive, not recruitingNCT06110156Not applicable
• Fentanyl OR Esketamine for Traumatic PAIN (FORE-PAIN) TrialTerminatedNCT06051227Phase 3
• Evaluation of Safety, Rate and Extent of Absorption of Psilocin MucateCompletedNCT06035900Phase 1
• Role of N-Acetylcysteine for Prevention of Cisplatin-induced NephrotoxicityActive, not recruitingNCT06019520Not applicable
• Retrospective Registry Study of Patients With Cancer Treated With High-dose MethotrexateStatus unknownNCT05899751
• An Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque PsoriasisCompletedNCT05858047Phase 2
• Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN)TerminatedNCT05847517Phase 3
• Peppermint Oil for the Treatment of Irritable Bowel Syndrome or Functional Abdominal Pain in Children: the MINT StudyCompletedNCT05799053Phase 3
• Collaborative Nurse-pharmacist Counseling for Self-administered BiologicsWithdrawnNCT05798104Not applicable
• Polypharmacy Among Internal Medicine PatientsActive, not recruitingNCT05756400
• Intensive Monitoring Scheme of Lidocaine CataplasmsStatus unknownNCT05645302
• Assessment of a Novel Algorithm System for Polypharmacy Patient Medication Safety and ConsultationCompletedNCT05589870
• Reduction of Polypharmacy in Elderly People With Multiple DiseasesCompletedNCT05526963Not applicable
• Personalised Therapeutics @LUMCActive, not recruitingNCT05508763
• Identifying Drug-related Problems at ED Triage (DRP-EDiT) V1Status unknownNCT05476705
• Efficacy and Safety of Perioperative Use of Breztri Aerosphere to Relieve Cough After LobectomyStatus unknownNCT05472350Not applicable
• Oliceridine in Patients With Acute Burn InjuriesCompletedNCT05465226Phase 4
• A Phase I Study of GC101 TIL in Advanced Solid TumorsCompletedNCT05417750Phase 1
• Impact of a Pharmacovigilance Program Led by Advanced Practice NursingCompletedNCT05402254Not applicable
• Possible Differences in HCC Course Depending on DAA TreatmentStatus unknownNCT05376943
• Neoadjuvant CRT Combined With Camrelizumab and Nimotuzumab for Initially Inoperable Patients With Esophageal CarcinomaCompletedNCT05355168Phase 2
• ASSIST: A Surveillance Study of Illicit Substance ToxicityStatus unknownNCT05329142
• Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.CompletedNCT05266300
• Medication Reviews in Severe Mental IllnessCompletedNCT05243160Not applicable
• The Influence of Tramadol on Platelet FunctionCompletedNCT05237492Phase 4
• Pharmacists' Knowledge and Attitudes About ADRs Reporting and Pharmacovigilance Practice in Egyptian HospitalsCompletedNCT05224804
• Research on Human Insulin rDNA Safety and Efficacy in Patients With Type 2 Diabetes MellitusCompletedNCT05161741Phase 4
• Safety of Pediatric COVID-19 VaccinationCompletedNCT05157191
• Lubiprostone for Functional Constipation in the Under 18 Years PatientsCompletedNCT05144295Phase 3
• A Study of Remitoro in Participants With Recurrent or Refractory Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma (All Case Study)CompletedNCT05137847
• Adverse Reactions Following COVID-19 Vaccination Among Ecuadorian Healthcare WorkersCompletedNCT05113472
• Trends of Acute Intoxication in Poison Control CentreStatus unknownNCT05098418
• Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate CancerActive, not recruitingNCT05096338
• Diagnosis, Antibiotic Prescribing Practices and Outcomes of cUTI in an Outpatient SettingCompletedNCT05091931
• Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast CancerActive, not recruitingNCT05078190
• Reduction of MTX Levels After Glucarpidase Treatment in DLBCL Patients at Risk of CNSTerminatedNCT05022797Phase 2
• Evaluation of Drug Overdose Poisoning Cases and Indications for ICU AdmissionStatus unknownNCT04987801
• Implementation of a Pharmacist-led Pharmacogenomic Clinical ServiceWithdrawnNCT04984538
• Role of Clinical Pharmacists in Epilepsy ManagementCompletedNCT04967326Phase 4
• Observation Study of the Pharmacokinetics of Adductor Canal BlockCompletedNCT04916392
• Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus AripiprazoleCompletedNCT04903353Phase 4
• Drug-Related Problems in Neonatal PatientsStatus unknownNCT04899960Not applicable
• Deprescription of Gabapentinoids in Medical InpatientsCompletedNCT04855578Not applicable
• The COVID-19 Back-to-Normal Study: Analysis of Multiple OutcomesActive, not recruitingNCT04832932
• Apatinib Plus IE Chemotherapy (Ifosfamide and Etoposide) for Relapsed or Refractory OsteosarcomaSuspendedNCT04824352Phase 2
• Polypharmacy and Associated Risk Factors and Clinical Outcomes for Surgical Patients Discharged From HospitalActive, not recruitingNCT04805151
• Rheumatologic Adverse Events and Cancer ImmunotherapyStatus unknownNCT04791150Not applicable
• Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic LeukemiaCompletedNCT04770922
• Spread and Scale of a Polypharmacy AppStatus unknownNCT04762303Not applicable
• Adverse Effects of Ivermectin Used in Egypt During COVID-19Status unknownNCT04747678
• Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic MalignancyStatus unknownNCT04743544
• NOCDURNA PASS Study Using Registries in Denmark, Germany and SwedenCompletedNCT04740645
• NORTH-REG Dwell-Time StudyActive, not recruitingNCT04701151Phase 4
• Drug-Related Problems : Focus on Age and DiabetesCompletedNCT04692220
• Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory OsteosarcomaCompletedNCT04690231Not applicable
• Antidote for Valproic Acid Toxicity: a New Indication for Meropenem Antibiotic.Status unknownNCT04671589Phase 4
• Medication Monitoring for Older Adults in Primary CareCompletedNCT04663360Not applicable
• Clinical Analysis of Safety in Latent Tuberculosis Infection Prophylaxis TreatmentStatus unknownNCT04655794
• Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine CarcinomasStatus unknownNCT04635956Phase 2
• Effect of a trAnSitional Pharmacist Intervention in geRiatric Inpatients on Hospitals Visits After dischargECompletedNCT04617340Not applicable
• Association Between Genetic Variant Scores and DOACs (DARES2)CompletedNCT04597593
• DOAC ADRs Retrospective Study on Genetic VariationsCompletedNCT04580589
• Evaluating ActionADE on Adverse Drug Event Due to Non-AdherenceStatus unknownNCT04574648Not applicable
• Evaluating ActionADE in Reducing Adverse Drug ReactionsStatus unknownNCT04568668Not applicable
• Reducing Costs by Deprescribing MedicationsCompletedNCT04553107Not applicable

← Drug-Related Side Effects and Adverse Reactions overview